ArticleRespiratory research2026
Hypoxia-preconditioned mesenchymal stromal cell-derived exosomes attenuate LPS-induced acute lung injury and early epithelial remodeling in mice: evidence for a miR-486a-5p-Skp2-GATA4 axis.
Article in Respiratory research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundAcute lung injury (ALI) can initiate early epithelial remodeling that may precede pulmonary fibrosis, with EMT of alveolar epithelial cells implicated in this acute phase. While mesenchymal stromal cell (MSC)-derived exosomes exhibit repair potential, their conventional culture conditions fail to mimic the hypoxic microenvironment of ALI. Here, we explored the therapeutic effects and regulatory mechanisms of hypoxia-preconditioned bone marrow MSC-derived exosomes (HExos) in LPS-induced ALI with early epithelial remodeling.
methodsBMSCs were characterized via osteogenic/adipogenic differentiation and flow cytometry. Exosomes derived under normoxia (NExos) and hypoxia (HExos) were isolated and validated using nanoparticle tracking analysis (NTA), transmission electron microscopy (TEM), and Western blot. An LPS-induced ALI mouse model was employed to evaluate exosome efficacy. Through integrated miRNA sequencing, luciferase reporter assays, and gain-/loss-of-function experiments, we examined a working model involving the miR-486a-5p/Skp2/GATA4 axis.
resultsHExos markedly alleviated LPS-induced acute lung injury and early-stage collagen deposition. Mechanistically, HExos were enriched with miR-486a-5p, which directly targeted Skp2, thereby reducing Skp2-mediated ubiquitin-proteasome degradation of GATA4 and attenuating EMT-like changes. Notably, miR-486a-5p mimics reversed EMT-like changes in alveolar epithelial cells, while its knockdown abolished the protective effect.
conclusionsHypoxia-preconditioned bone marrow-derived mesenchymal stromal cell (BMSC) exosomes demonstrate significant potential to alleviate LPS-induced acute injury and early epithelial remodeling by engaging a miR-486a-5p/Skp2/GATA4 working model, offering a proof-of-concept therapeutic strategy for ALI.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.